CSCR and the pachychoroid spectrum

The Pachychoroid Disease Spectrum Concept

The introduction of Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT) and long-wavelength Swept-Source OCT (SS-OCT) revolutionized our understanding of choroidal anatomy, giving rise to the modern concept of the pachychoroid disease spectrum (derived from the Greek pachy, meaning "thick").

Defining Morphological Hallmarks of Pachychoroid

The pachychoroid phenotype is characterized by four cardinal pathological criteria:

1. Choroidal morphology: Dilated outer choroidal vessels, attenuation of inner layers and regional thickness patterns support pachychoroid disease. Absolute thickness depends on age, axial length and other factors; 300–350 micrometres is not a compulsory diagnostic cutoff.
2. Pathologic Haller Layer Pachyvessels: Marked, asymmetric engorgement, ectasia, and tortuosity of the large venous and arteriolar vessels residing in the outer choroidal layer (Haller layer), known as "pachyvessels".
3. Choriocapillaris Compression and Atrophy: The massively expanded Haller layer pachyvessels physically displace and compress the overlying middle vascular layer (Sattler layer) and inner capillary layer (choriocapillaris). This mechanical compression produces severe localized attenuation, hypoperfusion, and ischemic loss of the choriocapillaris.
4. Overlying RPE Dysfunction: Ischemia and chronic hydrostatic pressure gradients from the underlying pachyvessels cause metabolic failure of the overlying retinal pigment epithelium (RPE), leading to focal pigment mottling, micro-rips, and outer blood-retinal barrier (BRB) breakdown.

The Evolutionary Continuum of Pachychoroid Disorders

The pachychoroid spectrum represents an evolutionary disease spectrum spanning four interconnected entities:

• 1. Pachychoroid Pigment Epitheliopathy (PPE): Considered the forme fruste and earliest stage of the spectrum. Characterized by focal or multifocal areas of RPE hypertrophy, hyperplasia, or atrophy located directly above dilated Haller layer pachyvessels, in the complete absence of subretinal fluid or history of CSCR. Often identified in the asymptomatic fellow eye of patients presenting with unilateral CSCR.
• 2. Central Serous Chorioretinopathy (CSCR): Characterized by active, localized neurosensory retinal detachment involving the fovea, frequently accompanied by small, focal serous pigment epithelial detachments (PEDs), driven by choroidal vascular hyperpermeability.
• 3. Pachychoroid Neovasculopathy (PNV): Chronic choriocapillaris ischemia and persistent outer retinal hypoxia over pachyvessels stimulate the growth of Type 1 macular neovascularisation (MNV) beneath the RPE. Unlike conventional neovascular AMD, PNV occurs in relatively young or middle-aged patients without drusen or typical AMD genetics, exhibiting shallow irregular PEDs on OCT.
• 4. Polypoidal Choroidal Vasculopathy (PCV / Aneurysmal Type 1 Neovascularisation): In eyes with longstanding PNV or primary pachychoroid congestion, high intravascular shear stresses induce aneurysmal dilatation of the abnormal vascular branches, forming terminal polypoidal ectasias. PCV manifests with extensive serosanguineous PEDs and vitreoretinal haemorrhages.

Pathophysiology and Systemic Risk Factors of CSCR

Central serous chorioretinopathy predominantly impacts individuals between 25 and 55 years of age, demonstrating a striking male preponderance (male-to-female ratio ~6:1).

The Pathophysiological Sequence

The development of CSCR follows a precise biomechanical sequence:

$$\text{Sympathetic / Glucocorticoid Surge} \implies \text{Choroidal Venous Hypertension} \implies \text{Pachyvessel Hyperpermeability} \implies \text{RPE Barrier Micro-Rip} \implies \text{Neurosensory Retinal Detachment}$$

1. Choroidal Vasomotor Dysregulation & Hyperpermeability: Sympathetic hyperactivation and elevated mineralocorticoid/glucocorticoid signaling produce severe focal stasis, vasoconstriction, and downstream venous hypertension within the vortex vein ampullae and Haller layer vessels. This elevated hydrostatic pressure causes widespread leakage of plasma and macromolecules into the choroidal stroma, visible on ICGA as choroidal vascular hyperpermeability.
2. RPE Hydrostatic Overload & Outer BRB Breakdown: The accumulation of interstitial fluid markedly increases extravascular pressure within the choroid. Hydrostatic pressure exerts continuous mechanical stress on the overlying RPE monolayer. When this exceeds the adhesive tensile strength of RPE intercellular tight junctions (zonula occludens, claudin-19), focal "micro-rips" or zones of functional decompensation breach the outer blood-retinal barrier.
3. Serous Subretinal Fluid Accumulation: Fluid is forced into the potential subretinal space between the RPE apical microvilli and photoreceptor outer segments, creating a circular, dome-shaped neurosensory retinal detachment.

Systemic Risk Factors: The Cardinal Role of Corticosteroids

• Exogenous Corticosteroids (The Cardinal Risk Factor): Exposure to exogenous steroids—administered via ANY route (oral, intravenous, intra-articular, inhaled, intranasal sprays, topical cutaneous creams, or periocular/ocular formulations)—is the single most potent independent trigger of CSCR. Corticosteroids upregulate endothelial mineralocorticoid receptors, promote choroidal hyperpermeability, impair RPE tight junction integrity, and impede RPE fluid resorption.

• Endogenous Hypercortisolemia: Pathologically elevated endogenous cortisol (Cushing syndrome, adrenal adenomas).
• Psychosocial Stress & Type A Personality: Elevated circulating catecholamines and sympathetic adrenergic tone.
• Sleep Disorders: Obstructive sleep apnoea (OSA), shift-work sleep disruptions.
• Other Associations: Pregnancy (third trimester, mediated by endogenous cortisol and progesterone), Helicobacter pylori infection, and phosphodiesterase-5 (PDE-5) inhibitors (sildenafil, tadalafil).

Multimodal Diagnostic Imaging in CSCR

Accurate diagnosis and differentiation of CSCR require multimodal retinal imaging:

1. Enhanced Depth Imaging & Swept-Source OCT (EDI-OCT / SS-OCT)

• Subretinal Fluid (SRF): Cross-sectional OCT reveals a smooth, dome-shaped elevation of the neurosensory retina separated from the RPE by an optically clear, hyporeflective fluid space.
• Elongated Photoreceptor Outer Segments: In acute CSCR, photoreceptor outer segments detached from the RPE can no longer be phagocytosed. They become swollen, elongated, and hyperreflective ("shaggy photoreceptors"). In chronic detachment, outer segments fragment into granular subretinal debris.
• Pachychoroid Signs: Markedly thickened subfoveal choroid with dilated, hyporeflective Haller vessels compressing the choriocapillaris, and small, irregular, shallow serous pigment epithelial detachments (PEDs).
• Fibrinous Subretinal Exudate: Hyperreflective sheets or mounds within the subretinal fluid space, representing fibrin leakage across severe RPE breakdowns.

2. Fundus Fluorescein Angiography (FA)

3. Indocyanine Green Angiography (ICGA)

ICGA is the gold-standard modality for visualizing the underlying choroidal vascular pathology:

• Early Phase: Demonstrates areas of delayed, irregular, or patchy choroidal filling.
• Mid Phase ($5-15\,\text{min}$): Reveals diffuse, multifocal zones of intense choroidal vascular hyperpermeability, with hazy leakage blurring the margins of engorged pachyvessels.
• Late Phase ($>20\,\text{min}$): Punctate hyperfluorescent spots and residual hyperfluorescent plaques at sites of choroidal congestion, alongside hypofluorescent wash-out halos.

Natural History and Evidence-Based Management

Acute CSCR often improves spontaneously, but recurrence, chronic fluid and outer-retinal atrophy can impair vision. Duration, prior episodes, fellow-eye status, occupational needs and imaging guide management. There is no compulsory observation period for every patient.

Review all steroid exposure, including inhaled, nasal, topical and systemic preparations. Coordinate reduction or alternatives with the prescribing clinician when possible; never abruptly stop medically necessary steroid therapy. Discuss smoking, sleep and associated health concerns without promising that modifying stress will cure the disease.

For persistent or recurrent CSCR, reduced-setting verteporfin photodynamic therapy (PDT) can be considered after excluding neovascularisation. PLACE compared half-dose PDT with high-density subthreshold micropulse laser. Complete subretinal-fluid resolution was 51.2% versus 13.8% at 6–8 weeks and 67.2% versus 28.8% at 7–8 months. These results do not directly establish identical effectiveness of half-fluence PDT, which is a different protocol. Treatment localisation and dose follow specialist imaging and safety criteria.

VICI found no meaningful benefit of eplerenone over placebo for chronic CSCR; it is not a routine fallback when PDT is unavailable. Anti-VEGF is used when secondary neovascularisation is present rather than for uncomplicated CSCR solely because fluid is visible. Selected extrafoveal focal leakage may be considered for laser, with a scotoma/expansion risk and avoidance of foveal injury.

Follow vision and OCT fluid/outer-retinal integrity and discuss recurrence symptoms. Pachychoroid includes several overlapping phenotypes, but a fixed choroidal-thickness cutoff does not define all cases and patients do not inevitably progress through a single sequence.